← FDA DRUG APPROVALS

FDA ANDA · ANDA202795

NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE

Sponsor: RISING

APPLICATION
ANDA202795
TYPE
ANDA
ORIGINAL APPROVAL
2013-01-24
LATEST ACTION
2013-01-24
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Over-the-counter

Products

NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATEOver-the-counter
NAPHAZOLINE HYDROCHLORIDE 0.025%, PHENIRAMINE MALEATE 0.3% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2013-01-24UNKNOWN · Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →